It is the dream of all medical scientists to harness biotechnologies to reorganize the "code of health" and improve the quality of human life. With the advancement of medical technology, biomedicine has replaced traditional drug-based treatment and becomes the mainstream in the medicine field in the 21st century. Driven by the development of high-throughput sequencing technology, medicine is accelerating transition into the era of genomics and biomedicine. The analysis and management of large-scale genomic data have become the the driving force for the development of genomics and biomedicine.

Massive Screening
Monpellerin uses the Hadoop and ZeroCostDL4Mic platform to perform multi-dimensional and correlational screening among basic data, diagnosis and treatment data and health data.

Accurate Identification
Using genetic quantitative analysis technology, it performs high-throughput sequencing analysis on the transcriptomes of various diseases which can accurately identify recurrent mutated pathogenic genes based on the differences in gene expression levels.

Products Innovation
Conduting the long and rigorous journey of countless in vitro experiments, animal experiments and human clinical trials, the research results have been translated into different innovative products which are improving human health.

AI Technology
Harnessing advanced AI technology to densely screen thousands of probiotical strains so as to identify the target strains that can exert therapeutic effects against specific diseases.

It is the mission bestowed upon Monpellerin by the times to integrate biotechnology with AI technology through translational medicine in every stage from the fundamental drug researches to clinical application. As a mission fulfiller, Monpellerin will take on the responsibility of the times and answer to its promise of safeguarding human's health with tangible actions.